EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial

Saman Fatima, Manjari Tripathi

Epilepsia · 2026-11-20

DOI: 10.1002/epi.70601 ↗

At a glance

Randomisierte kontrollierte Studie in Epilepsia, published online on 2026-11-20. Written by Saman Fatima and 1 co-authors. 3 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Fatima, S., & Tripathi, M. (2026). Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. https://doi.org/10.1002/epi.70601

Vancouver

Fatima S, Tripathi M. Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. 2026. doi:10.1002/epi.70601

BibTeX
@article{Fatima2026,
  author = {Fatima, Saman and Tripathi, Manjari},
  title = {Response: Concerns regarding intranasal midazolam vs mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70601}
}
Start for free →